Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +15.60p +0.95% 1,651.80p 1,652.40p 1,653.20p 1,666.60p 1,629.80p 1,659.00p 9,116,649 16:35:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 30,821.0 4,048.0 73.7 22.4 82,003

Glaxosmithkline Share Discussion Threads

Showing 19526 to 19549 of 20175 messages
Chat Pages: Latest  783  782  781  780  779  778  777  776  775  774  773  772  Older
DateSubjectAuthorDiscuss
11/4/2019
15:54
Dividend payment in accounts today, so I've started buying for the next xd …. ;0)
tradermichael
10/4/2019
06:01
The Times (Tempus share tips): HOLD #Glaxosmithkline; HOLD #Smart #Metering #Systems. https://twitter.com/smallcappick/status/1115842187726606337
newtothisgame3
09/4/2019
08:45
Buybadly - you are an unreconstructed ramper please go forth an multiply and do not darken this board with your complete and utter drivel (and take your pseudonyms with you) love peace and buns
toffeeman
09/4/2019
08:29
Buy well, agree this is a great little company, part of a collection of hi tech med type companies I own
ayl30
09/4/2019
08:16
I chose the company SDI and 3 years as the timeframe because the new BOD have been implementing a new strategy for growth of buying UK small caps that have little debt, turnover around 1.5M to 2M and profit making circa 0.5M. There are apparently quite a number of family type businesses in the 'Sciences' area that fall into this niche where older folks want now to retire plus Brexit has reduced their price expectations such that they can be acquired in many cases at 3 to 5 times net profits and under or very close to recent turnover. ALL acquired companies are accreditive in their first year after acquisition. Therefore record turnover and profits are assured not only this year, final results july 2019 but also even BIGGER record results to follow the next year after. I kid you not dyor. Here is why , SDI have just picked up 3 such fits … where X selling opportunities exist within the ever growing Group of companies , which fall into at present 5 main scientific Segments for bargain prices … within the last 2 months. hTtps://scientificdigitalimaging.com/ Scientific Digital Imaging designs and manufactures scientific products for use in applications including life sciences, healthcare, astronomy, consumer manufacturing and art conservation markets. It would not surprise me if GSK are using or considering using a new novel product recently developed and now on sale.
buywell2
08/4/2019
11:19
I intend to top-up with the next payout which is 11 April …. (23p per share) ;0)
tradermichael
08/4/2019
11:18
Not long to go …. Ex-dividend date Thursday 16 May 2019
tradermichael
06/4/2019
07:30
Of course, options trading, regular trading or spreadbetting, the point I'm making is that GSK can be bought and sold on the swings. And, all the time, take a position four times a year for the dividend.
tradermichael
05/4/2019
17:10
The opposite is also true TM. I sell high and re-invest low, it works both ways 'till it does'nt :-)
sicker
05/4/2019
16:52
Nah you can spreadbet
toffeeman
05/4/2019
16:48
You're correct ;0)
tradermichael
05/4/2019
16:31
But to play this way you will need a loads of ready cash.
abdullla
05/4/2019
16:22
GSK can be bought and sold on the swings. Buy lower, sell higher. Then repeat on the next swing. It doesn't have to be the very bottom or the very top, just in short time spans, with a large amount of money and skim for steady small gains. All the time, take a position four times a year for the dividend.
tradermichael
05/4/2019
16:11
My point is although nothing is guaranteed a share like GSK generally plods on for years and pays a steady dividend every few months.With smaller cap shares you are often buying something with far greater volatility and potential for loss and gain and sdi went for years doing nothing and not paying a dividend.Much is down to your appetite for risk and investment objectives.
tim 3
05/4/2019
14:28
One is much more likely to pick a real dud in the small cap market (eg Patisserie Valerie which ticked all the right boxes right up to the end) than in larger caps. As Tim3 implies, it's easy to prove how wise you are if you select statistics and time frames to suit your own thesis. A mix of high dividend yield large caps with small caps which pay more modest dividends works out even better over the long term. Twenty years of serious investing has taught me that - even with the occasional dramatic mistake in both small and large caps. Provided I hit around 7 out of 10 shares right, I am happy.... and reasonably successful in terms of dividends and growth.
grahamburn
05/4/2019
10:08
In that time frame yes but look at a longer timeframe say 2010 to 2017 and sdi basically went nowhere where as although gsk only went up a little you had a decent dividend each year which if reinvested would have given a much better performance.
tim 3
05/4/2019
10:06
Buywell - if you must ramp be honest and use the data from 2007 when SDI was £17 as opposed to 50p today.
toffeeman
05/4/2019
09:42
You guys probably think you are doing very well invested in GSK Well ... don't you ? .... come on admit it you do. Remember Ashley James ? He was my mentor ... crossed swords on another website before advfn was born when I was just a big-headed young upstart. I learnt a lot from Ashley and though we argued a lot ... I liked and respected his views ... even when he was wrong , hahaha Ash. Unfortunately he is no longer with us so today I have tried to help those less savvy investors on some other threads ... like Ash helped me ... by asking them to open their minds to looking at quality UK Small Cap Stocks , well managed , and with the right growth strategy in place. ''Dividends are NOT the be all and end all'', I have argued. ''Using company cash to buy more profit making company's is a better way'', I have said. I used a 3 year comparison chart of SDI V their company Barclays Bank, Lloyds Bank, Aviva, BP , and Glaxo Smith Kline were my choices All FTSE 100 stocks ... all paying dividends ... and in a mix of sectors seen as safe ... by some ... not me I would add. It was a NO CONTEST ... and SDI was a winner by knockout in each and every case Here it is in one picture GSK are in there at the bottom
buywell2
04/4/2019
13:06
Yesterday was a buying day.
abdullla
04/4/2019
12:15
Did you sell yesterday?
tradermichael
04/4/2019
10:11
Sold out at just over 16, phew, will watch them do the usual and slide back to the low 15's. Totally range bound. People bang on about the divi which is ok but there are income funds that pay more without the stock specific risk, if you want capital growth buy astra on weakness, amazing pipeline which Glaxo is a decade behind.
porsche1945
03/4/2019
16:34
”ViiV Healthcare's Juluca shows sustained treatment effect in studies” Three year results from the SWORD 1 & 2 studies. The results demonstrate that 84% (432/513) of participants who switched from their current three- or four-drug antiretroviral regimen to a 2-drug regimen of Juluca (dolutegravir/rilpivirine) maintained viral suppression (viral load ≤50 copies/mL) and showed tolerability and resistance. hTTps://seekingalpha.com/news/3448006-viiv-healthcares-juluca-shows-sustained-treatment-effect-studies
wbecki
03/4/2019
14:28
Shorts opening over £16? Been selling off over £16 for months.
tim 3
02/4/2019
23:04
Yes going - took me 6 hours on ticketmaster to get them. Should be a good game - not much in the teams
watfordhornet
Chat Pages: Latest  783  782  781  780  779  778  777  776  775  774  773  772  Older
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191017 17:55:41